11 recruiting. 11 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Recruiting 11 |
| Phase 1 | 3 | Recruiting 3 |
Follow Foot Ulcer: new trials by email Literature Review of Foot Ulcer trials Research Report on Foot Ulcer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of L-Carnitine on Wound Healing in Patients With Diabetic Foot Ulcer. L- carnitine - Diabetic Foot Ulcer, Diabetic Foot Ulcer (DFU) | Phase 2 | Recruiting | Ain Shams University | 50 | 2026-09-01 | 2026-08-17 |
| Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU Antimicrobial agent - Diabetic Foot Ulcers (DFUs) | Phase 2 | Recruiting | Lakewood-Amedex Inc | 24 | 2026-08-14 | 2026-09-02 |
| Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care Standard of Care (SOC), SoC + Low dose CYWC628, SoC + High dose CYWC628 - Diabetic Foot Ulcer (DFU) | Phase 1 / Phase 2 | Recruiting | FibroBiologics | 120 | 2026-06-01 | 2026-08-26 |
| Effects of Transcutaneous Photobiomodulation on Diabetic Foot Ulcers. PBM - Photobiomodulation, Placebo PBM, Standard Treatment - Diabetes Mellitus, Foot Ulcer | Phase 2 | Recruiting | University of Nove de Julho | 20 | 2026-05-12 | 2026-09-04 |
| Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers ELU42 Topical Spray - Diabetic Foot Ulcer, Wagner Grade 1 - 2 | Phase 1 / Phase 2 | Recruiting | Eluciderm Inc | 15 | 2025-11-10 | 2026-02-12 |
| Safety and Preliminary Efficacy of TrophiPatch, an Adipose-Derived Stromal Cell Patch for Chronic Leg Ulcers TrophiPatch: allogeneic adipose-derived stromal cell patch - Diabetic Foot Ulcer (DFU), Venous Leg Ulcer (VLU) | Phase 1 / Phase 2 | Recruiting | Nicolò Brembilla | 18 | 2025-07-01 | 2025-07-02 |
| Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care. Platelet Rich Plasma - Diabetic Foot Ulcer, Type 1 Diabetes Mellitus | Phase 2 | Recruiting | Estar Medical dba Medical Technologies, LTD | 30 | 2025-04-15 | 2025-06-12 |
| A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers 0.75% MDI-1228_mesylate gel plus Standard of Care, Standard of Care Alone - Diabetic Foot Ulcer | Phase 2 | Recruiting | Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd. | 60 | 2025-03-12 | 2025-03-07 |
| Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot Syndrome. Allogeneic ADSC/ASC (alloADSC-DFU-RL), Placebo (PL-DFU-RL) - Diabetic Foot Ulcer | Phase 2 | Recruiting | Medical University of Warsaw | 105 | 2025-03-05 | 2026-10-26 |
| BB-101 for the Treatment of Diabetic Lower Leg and Foot Ulcers BB-101 - Diabetic Foot Ulcer | Phase 2 | Recruiting | Blue Blood Biotech Corp. | 96 | 2024-05-01 | 2026-10-02 |
| Smart Boot Use to Measure Offloading Adherence Offloading Boot - Diabetic Foot Ulcer | Phase 2 | Recruiting | University of Southern California | 210 | 2021-10-19 | 2026-01-16 |
Diabetic Foot (10) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Infections (1) · Leg Ulcer (1) · Varicose Ulcer (1)
Endocrine System Diseases (11) · Skin Diseases (11) · Skin Ulcer (11) · Skin and Connective Tissue Diseases (11) · Cardiovascular Diseases (10) · Diabetes Complications (10) · Diabetic Angiopathies (10) · Diabetic Neuropathies (10) · Leg Ulcer (10) · Vascular Diseases (10) · Diabetes Mellitus (9) · Foot Diseases (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3)
Standard of Care (2) · Anti-Infective Agents (1) · Carnitine (1) · Low-Level Light Therapy (1)
Ain Shams University (1) · Blue Blood Biotech Corp. (1) · Eluciderm Inc (1) · Estar Medical dba Medical Technologies, LTD (1) · FibroBiologics (1) · Lakewood-Amedex Inc (1) · Medical University of Warsaw (1) · Nicolò Brembilla (1) · University of Nove de Julho (1) · University of Southern California (1) · Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd. (1)
United States (5) · Australia (1) · Brazil (1) · Egypt (1) · Poland (1) · Switzerland (1) · Taiwan (1)
Adrianne P Smith, MD (1) · Beata Mrozikiewicz-Rakowska, Assoc.Prof. (1) · David G Armstrong, DPN, MD, PhD (1) · Marcus L. Gitterle, MD (1) · Shug-Cheng Chang, MD (1)